Mudryk four-year – Mykhailo Mudryk has been handed a four-year anti-doping ban by the FA and will appeal to CAS. The Chelsea winger has not played since 2024 as the case moves forward.
Chelsea winger Mykhailo Mudryk has received a maximum four-year ban for an anti-doping rule breach, and he is now preparing to challenge the decision at the Court of Arbitration for Sport.
Mudryk’s name first came under spotlight in 2024 after a routine urine test raised an adverse finding.. He was provisionally sidelined soon after. and although Chelsea later provided explanations for his absence. the case has now reached the point where the Football Association issued a four-year sanction—an outcome that Mudryk says he does not accept and will contest.
The FA ban marks a major rupture in the player’s Chelsea career. not only because of the length of the suspension. but because Mudryk arrived in west London with enormous expectations.. Signed from Shakhtar Donetsk in 2023 for a fee that rose as high as £88 million. the 25-year-old quickly became one of the Premier League’s most closely watched attacking prospects.. Yet his competitive absence has already spanned much of the last year and a half. and Misryoum understands that his situation is now entering a longer. more uncertain phase—one defined by legal timelines rather than matchday form.
According to Misryoum’s reporting on the latest procedural step. Mudryk lodged an appeal after the FA decision. and a CAS hearing has not yet been scheduled.. A Chelsea spokesperson and Mudryk’s representatives have not publicly changed the fundamentals of the case: the ban exists. the player is contesting it. and the clock on his eligibility continues until CAS reaches a final ruling.
The substance at the heart of the matter is meldonium. a drug that has repeatedly appeared in elite sport’s doping history.. Its name is familiar to fans partly because it featured in the tennis scandal involving Maria Sharapova. who received a two-year ban in 2016 after a positive test at the Australian Open.. Meldonium. sold under the brand Mildronate. has been at the center of debates about intent. effects. and proper use—arguments that surface again whenever the drug returns to the sport’s headlines.
For Chelsea. the immediate impact is obvious: the club is without a high-value attacking asset and faces the practical challenge of planning without him while an appeal runs its course.. Financially. a four-year suspension is not only a sporting loss but also a potential long-term reputational and squad-structure issue. particularly for a club trying to build stability after years of turnover.. Even with contracts extending far into the future. Misryoum sees the same sports-business reality: without first-team availability. value is measured in training ground output and market perception—areas that inevitably shift when legal processes take over.
There’s also a human dimension that is easy to overlook when a case becomes paperwork.. Mudryk has continued training independently. including renting pitch time at a non-League venue. reflecting how players try to preserve sharpness while locked out of competitive football.. Misryoum understands that for athletes at this stage of a career. long gaps don’t just stall development—they also affect rhythm. confidence. and the simple momentum that comes from playing week after week.
Analytically, the four-year length is the most striking part of the sanction.. Maximum bans are intended to send a clear message about rule compliance. but they also heighten the stakes of the appeal.. Misryoum notes that similar cases have seen reductions elsewhere when CAS intervenes—while timelines can stretch. the final outcome often depends on how the sanction’s duration is justified under the specific circumstances of the violation.
If the four-year ban is applied in full from when the player’s ineligibility effectively began. it could carry Mudryk into the final quarter of 2028. potentially turning a single anti-doping decision into a near end-to-end career interruption.. That prospect places pressure not only on Mudryk’s legal strategy. but also on Chelsea’s forward planning: the longer the case lingers. the more the club must hedge its attacking options to avoid being structurally exposed.
Whatever CAS decides. the next chapter for Mudryk will be defined less by tactics and more by procedure—hearings. arguments. and legal reasoning.. For now. Chelsea’s £88 million signing remains in limbo. and the question for football’s wider audience is simple: will the appeal change the duration. or will the four-year penalty stand and reshape the rest of his career?